A new trading day began on Monday, with Prothena Corporation plc (NASDAQ: PRTA) stock price down -7.46% from the previous day of trading, before settling in for the closing price of $16.21. PRTA’s price has ranged from $13.22 to $41.54 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 4680.14% over the last five years. Meanwhile, its annual earnings per share averaged 20.56%. With a float of $44.79 million, this company’s outstanding shares have now reached $53.81 million.
The firm has a total of 173 workers. Let’s measure their productivity. In terms of profitability, gross margin is 45.5%, operating margin of -126.12%, and the pretax margin is -105.02%.
Prothena Corporation plc (PRTA) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Prothena Corporation plc is 16.77%, while institutional ownership is 94.74%. The most recent insider transaction that took place on Jan 24 ’24, was worth 170,000. In this transaction Chief Accounting Officer of this company sold 5,000 shares at a rate of $34.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Dec 20 ’23, when Company’s Chief Accounting Officer sold 5,000 for $37.19, making the entire transaction worth $185,952. This insider now owns 0 shares in total.
Prothena Corporation plc (PRTA) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -1.26 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.56% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 34.07% during the next five years compared to 6.83% growth over the previous five years of trading.
Prothena Corporation plc (NASDAQ: PRTA) Trading Performance Indicators
Here are Prothena Corporation plc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.52. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.48, a number that is poised to hit -1.00 in the next quarter and is forecasted to reach -3.97 in one year’s time.
Technical Analysis of Prothena Corporation plc (PRTA)
Analysing the last 5-days average volume posted by the [Prothena Corporation plc, PRTA], we can find that recorded value of 0.44 million was lower than the volume posted last year of 0.58 million. As of the previous 9 days, the stock’s Stochastic %D was 77.09%. Additionally, its Average True Range was 1.10.
During the past 100 days, Prothena Corporation plc’s (PRTA) raw stochastic average was set at 14.59%, which indicates a significant decrease from 37.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.67% in the past 14 days, which was higher than the 63.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.90, while its 200-day Moving Average is $21.26. Now, the first resistance to watch is $16.11. This is followed by the second major resistance level at $17.21. The third major resistance level sits at $17.80. If the price goes on to break the first support level at $14.41, it is likely to go to the next support level at $13.82. Should the price break the second support level, the third support level stands at $12.72.
Prothena Corporation plc (NASDAQ: PRTA) Key Stats
With a market capitalization of 807.13 million, the company has a total of 53,809K Shares Outstanding. Currently, annual sales are 91,370 K while annual income is -147,030 K. The company’s previous quarter sales were 970 K while its latest quarter income was -59,000 K.
